Tuesday, August 4, 2026
Your Source for Dental Industry Intelligence

How Do Associate Buy-Ins Actually Work?

Associate buy-ins turn on what is being bought, how it is priced, how it gets paid for, and what happens when partners disagree.
Share :

An associate buy-in is the sale of a partial ownership interest to a dentist already working in your practice. Four things determine whether it holds together: what exactly is being purchased, how it is priced, how the associate pays for it, and what the governing documents say happens when the two of you disagree.

The last item is where buy-ins fail, and it is the one almost nobody negotiates carefully at the start. What follows describes structures generally. Partnership terms carry legal and tax consequences that require your own attorney and CPA.

What is actually being sold?

Two broad structures exist and they are not interchangeable.

Equity. The associate purchases a share of the entity and becomes a co-owner. Profit is shared according to the operating agreement, and both parties carry exposure to the practice’s obligations.

Cost sharing. The two doctors keep separate books, split shared costs on an agreed formula, and never share a single earnings stream. Simpler to unwind and less integrated, which is either the point or the problem depending on what you want.

Within an equity deal, the way the transaction is structured has tax consequences that differ for buyer and seller, and their preferences often point in opposite directions. Each side needs its own CPA before the structure gets chosen, not after.

How does the price get set?

Start with a valuation of the whole practice, then take a proportional share. Nearly every deal adjusts from there.

A seller may apply a discount reflecting that a non-controlling stake carries less value per point than a controlling one. A buyer may argue that some of the current value exists because of their own production and should not be sold back to them. Both positions are legitimate, and the resolution is a negotiation rather than a calculation.

Two structural questions matter as much as the price:

  • Is this a single transaction or a staged purchase toward a target share?
  • Is the price fixed at today’s valuation, or recalculated at each stage?

Pricing each stage at the time means an associate who grows the practice pays more for the growth they created. Fixing the price up front avoids that and exposes the seller if the practice appreciates. Neither is wrong. Say which one you are doing, in writing, before anyone signs.

How does the associate pay for it?

Three mechanisms, often combined.

  • Outside financing. The associate borrows and pays the seller at closing. A lender will have its own requirements about the practice’s performance and the borrower’s history, so ask one early what they need to see. That answer shapes which structures are even possible.
  • Seller financing. The seller carries a note. It creates flexibility and it makes you both partner and creditor, which is a complicated pair of hats to wear at the same meeting.
  • Earn-in. Ownership accrues as the associate’s share of profit is applied against the price. Requires precise accounting and can create tax consequences worth understanding before, rather than during.

What has to be in the documents?

Settle in advance and in writing: how each owner’s compensation is calculated and whether it tracks production or profit; who decides on hiring, firing, and capital purchases, and above what size; what happens if a partner becomes disabled or dies; how a partner exits voluntarily and how their interest gets valued at that moment; whether a buy-sell agreement exists and how it is funded; what breaks a deadlock; and whether a non-compete applies and what it covers.

The exit valuation method deserves particular attention. Agreeing now on the formula that will price a departure later removes the most common source of partnership litigation.

Use separate advisors from the other party. Shared counsel in a two-party transaction is a false economy that gets discovered at the worst possible time.

FAQ

Should a buy-in happen before or after the associate proves out?
A seller has good reason to want a track record first: stable production, patient retention, cultural fit. That period also lets the associate see the real numbers. Setting explicit criteria and a timeline at hire prevents the drift that leaves associates waiting on a conversation nobody ever starts.

How large a share should an associate buy?
The share matters less than the governance attached to it. A minority owner with no decision rights and a partner holding veto power over everything both produce predictable friction. Decide what authority travels with the ownership, then let the arithmetic follow that decision rather than driving it.

What happens if the partnership fails?
Whatever your documents say, which is the entire argument for drafting them carefully. Good language specifies how a departing interest is valued, over what period it is paid, and what restrictions follow. Without it, you negotiate during the worst moment available, with lawyers billing both sides.

filed under

Practice Growth & Leadership

About the author

The Editorial Board

The Editorial Board writes independent research on practice growth, marketing, financial strategy, clinical education, and the health and wellness of doctors.

Most Popular

Not all debt behaves the same. How to compare student loans, practice acquisition debt, and real estate loans when deciding what to attack.
It’s the kind of conversation that shapes the rest of your financial journey—not just for some mystical future “retirement age,” but for every phase of life.
The transaction is the short part. A working sequence for practice exit planning, from operational groundwork to the final stretch.